Chemocentryx

Developing orphan drugs for multiple diseases

placeMountain View, California, United States calendar_todayFounded 1997 groups178 employees language chemocentryx.com

Registered entities

Innovation

161 patent families (126 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 22,976 times.

YearFilings
201522
201625
201735
201834
201946
202047
202156
202255
202354
202444
202538
202615

Investor mix

12 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital433%
Private equity325%
Bank & private debt18%
Other / undisclosed433%
Coming soon